Joint Programming Initiative on Antimicrobial Resistance

Hem
Sverige
Stockholm
Joint Programming Initiative on Antimicrobial Resistance

The Joint Programming Initiative on Antimicrobial Resistance. Coordinates global research and funding. 29 member nations.

Antimicrobial resistance is a global problem that presents a major public health challenge. The aim of JPIAMR is to integrate relevant research activities across national borders. The need for this initiative is obvious – bacteria and other infecting agents know no borders and therefore trans-national cooperation is crucial. A shared strategic research and innovation agenda guides the research funding. JPIAMR provides the forums and funding platform to conduct the joint actions that are urgently needed for understanding and curbing AMR on a global scale. The following 29 participating countries have dedicated their commitment to the success of the initiative: Argentina, Belgium, Canada, Chile, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, India, Ireland, Israel, Italy, Japan, Moldova, Norway, Poland, Romania, South Africa, South Korea, Spain, Sweden, Switzerland, , The Netherlands, Turkey, and United Kingdom.

08/02/2024

Please follow JPIAMR on Linkedin for news and updates about calls and events.

https://www.linkedin.com/company/jpiamr/

16/01/2023

The call is open!
A joint research call on and ! Est. budget: 18.8 Million Euro.
18 countries participate, providing funding for researchers in national contexts.
See call page: https://jpiamr.eu/calls/diagnostics-surveillance-call-2023/.

05/12/2022

It's open!
We invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the Research and Innovations Objectives!
👉 https://www.jpiamr.eu/open-consultation-oh-amr-research-and-innovation-objectives/

21/11/2022

We are happy to share the results from the 14th JPIAMR call!
It aims to improve the treatment of bacterial and fungal infections, to prevent the spread of resistance in humans, animals, or plants by improving drugs and plant protection agents. . Please view the projects recommended for funding here: www.jpiamr.eu/calls/therapeutics-call-2022/

20/11/2022

We are happy to share the results from the JPIAMR 15th call for networks! Six networks are recommended for funding! With an intent to facilitate the development and use of diagnostic and surveillance tools, technologies, and systems!
👉 https://www.jpiamr.eu/calls/network-call-2022/

18/11/2022

Pre-announcement of joint research call on and ! Est. budget: €18.8 M.
Australia joins a call for the first time!
18 countries participate in this call, providing funding for researchers in national contexts.
👉 https://lnkd.in/dpK8gJPK

05/07/2022

"Preventing antimicrobial resistance together"
Excellent theme for this year's World Antibiotic Awareness Week! 👉http://createsend.com/t/d-AFC3192DB8A403632540EF23F30FEDED

22/06/2022

JPIAMR, in partnership with the Israeli Ministry of Health משרד הבריאות and the U.K:s Medical Research Council, hosts a live webinar to discuss fungal drug resistance. Join the experts! Help us prioritize and advance the research topics!
Limited space, please register here: https://www.jpiamr.eu/.../tackling-the-emerging-threat.../

14/06/2022

Soon!
JPIAMR, in partnership with U.Ks Medical Research Council and BactiVac Network, hosts a live webinar to identify opportunities and priorities for vaccine research. Vaccinations are effective in promoting the prudent use of antibiotics and preventing the spread of .
Register here: https://www.jpiamr.eu/events/vaccination-as-a-strategy-to-combat-antimicrobial-resistance/

10/06/2022

Have your say in directing the future of !

We are happy to host this workshop with KTN! We will explore the main barriers to the industry in developing novel antibacterial drugs for humans and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.

Join here 👉 https://www.jpiamr.eu/events/developing-novel-antimicrobial-therapeutics/

08/06/2022

We are happy to host two roundtables with the International Centre for Antimicrobial Resistance Solutions (ICARS)!
Join us and discuss gaps and opportunities for and research. Contribute to updating the JPIAMR
Strategic Research and Innovation Agenda!

The objectives of the webinar are to:
1. Reflect on the area of prevention and intervention to mitigate AMR across all sectors.
2. Discuss and identify gaps and opportunities to reflect on progress made over the past 5 years.
3. Identify areas of research that would need to be incorporated to reflect a global AMR perspective.

The webinar will take place over two days, with different speakers to suit multiple time zones – but the agenda will be the same.

Register here 👉 https://jpiamr.eu/events/supporting-measures-to-mitigate-amr-in-one-health-settings/

31/05/2022

JPIAMR, in partnership with the Israeli Ministry of Health משרד הבריאות and the U.K:s Medical Research Council, hosts a live webinar to discuss fungal drug resistance. Join the experts! Help us prioritize and advance the research topics!

Limited space, please register here: https://www.jpiamr.eu/events/tackling-the-emerging-threat-of-fungal-drug-resistance/

Adress

Hantverkargatan 11B
Stockholm
11221

Telefon

+46854644000

Webbplats

http://www.jpiamr.eu/

Aviseringar

Var den första att veta och låt oss skicka ett mail när Joint Programming Initiative on Antimicrobial Resistance postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Praktiken

Skicka ett meddelande till Joint Programming Initiative on Antimicrobial Resistance:

Genvägar

Vill du placera din praktik längst upp i Klinik-listan i Stockholm?

Dela

Typ

Medicin och hälsa